Page last updated: 2024-10-15

dinitrochlorobenzene and Carcinoma in Situ

dinitrochlorobenzene has been researched along with Carcinoma in Situ in 2 studies

Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.

Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jakse, G1
Hofstädter, F1
Märk, R1
Foster, DC1
Woodruff, JD1

Other Studies

2 other studies available for dinitrochlorobenzene and Carcinoma in Situ

ArticleYear
Specific red cell adherence test and unspecific immune response in patients with superficial bladder cancer.
    Urologia internationalis, 1981, Volume: 36, Issue:3

    Topics: Aged; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotaxis, Leukocyte; Dinitrochlorobenzene;

1981
The use of dinitrochlorobenzene in the treatment of vulvar carcinoma in situ.
    Gynecologic oncology, 1981, Volume: 11, Issue:3

    Topics: Administration, Topical; Adult; Carcinoma in Situ; Dinitrochlorobenzene; Female; Fluorouracil; Human

1981